Oura announced Tuesday it is acquiring AI-native primary care company Counsel Health for $625 million. The acquisition follows Oura's decision to indefinitely postpone a potential IPO valued at up to $2.2 billion due to market uncertainty. The deal, which is expected to close before the end of 2027, will see Counsel Health's 70 employees join Oura, with Counsel CEO Muthu Alagappan becoming the company's chief clinical AI officer.
Counsel Health provides an AI-powered healthcare platform that integrates chat-based medical experiences with access to licensed physicians. While the two companies began integrating services into the Oura app in June, the acquisition aims to expand their partnership into preventative, acute, specialty, and chronic care. Oura CEO Tom Hale said, “Oura helps members understand their physiology and, with Counsel, they can take action on their health across a range of needs, from quick questions and prescriptions to lab results, chronic care, and referrals.”
Prior to the acquisition, Counsel Health had raised an estimated $36 million in total funding, including a $25 million Series A led by Andreessen Horowitz and GV. Following the deal, Counsel Health will continue to serve existing and new enterprise partners as Oura seeks to expand the AI-native care model beyond its current membership.
Oura reported significant financial growth alongside the acquisition announcement. The company stated revenue grew 153% year-over-year to $533 million for the quarter ended September 30. For fiscal year 2026, Oura generated approximately $1.75 billion in revenue, representing 92% year-over-year growth. The company reached an $11 billion valuation following a $900 million funding round in October 2025.
